2017-4

SUBJECT INDEX 2017
Single nucleotide polymorphisms / Tek nükleoitid polimorfizm, 174
Ph-negative myeloproliferative neoplasms /
Ph-negatif Miyeloproliferatif neoplaziler, 174
Bing-Neel syndrome / Bing-Neel sendromu, 186
Waldenström’s macroglobulinemia / Waldenström
makroglobulinemisi, 186
Central nervous system / Merkezi sinir sistemi, 186
MYD88 L265P mutation / MYD88 L265P mutasyonu, 186
Cerebrospinal fluid / Beyin-omurilik sıvısı, 186
Leukemia / Lösemi, 89, 109, 126, 186, 190
Adult / Erişkin, 196, 366
Sickle cell anemia / Orak hücreli anemi, 196, 358
Genetic counseling / Genetik danışmanlık, 196
Transplantation / Transplantasyon, 102, 196
Myelodysplastic syndromes / Miyelodisplastik sendromlar, 200
Telomere-binding proteins / Telomer-bağlayıcı proteinler, 200
Reverse transcription-polymerase chain reaction /
Ters transkripsiyon-polimeraz zincir reaksiyonu, 200
International Prognostic Scoring System /
Uluslararası Prognoz Skorlama Sistemi, 200
World Health Organization Prognostic Scoring System /
Dünya Sağlık Örgütü Prognoz Skorlama Sistemi, 200
MicroRNA-155 / MikroRNA-155, 207
Non-Hodgkin lymphoma / Hodgkin dışı lenfoma, 207, 378, 381
Immunoregulatory effect / Bağışıklık baskılayıcı etki, 213
Co-culture / Ko-kültür, 213
Mesenchymal stem cells / Mezenkimal kök hücre, 213
T cells / T hücre, 213
Thalassemia / Talasemi, 258
Sickle/β-thalassemia / Orak/β talasemi, 258
Codon / Kodon, 258
Genotype / Genotip, 258
Phenotype / Fenotip, 258, 374
Wolman disease / Wolman hastalığı, 264
Hemophagocytic lymphohistiocytosis /
Hemafagositik lenfohistiyositozis, 264
Hemophagocytosis / Hemofagositoz, 264
Hemophilia A / Hemofili A, 278
FVIII gene / FVIII geni, 278
Intron 1 / İntron 1, 278
Polymerase chain reaction / Polimeraz zincirleme reaksiyonu, 278
Pakistan / Pakistan, 278
Essential thrombocythemia / Esansiyel trombositemi, 360
Primary myelofibrosis / Primer miyelofibroz, 124, 360
Calreticulin / Kalretikulin, 360
EZH2 / EZH2, 366
T-cell / T-hücre, 366
Abnormal hemoglobins / Anormal hemoglobinler, 372
Hemoglobin San Diego / Hemoglobin San Diego, 372
Hemoglobin variant / Hemoglobin varyantı, 372
Para-Bombay / Para-Bombay, 374
FUT1 gene / FUT1 geni, 374
Blood transfusion / Kan transfüzyonu, 374
Myopathy / Miyopati, 376
Lactic acidosis / Laktik asidoz, 376
Sideroblastic anemia / Sideroblastik anemi, 376
miR-155 / miR-155, 381
Prognostic value / Prognostik değer, 381
Gene mutation / Gen mutasyonu, 300
FLT3 / FLT3, 300
NPM1 / NPM1, 300
Multiple Myeloma
Multiple myeloma / Multipl miyelom, 131, 184, 226, 233, 282
Prognostic factors / Prognostik faktörler, 131
Serum immunoglobulins / Serum immünglobulin, 131
Nephelometric measurement / Nefelometrik ölçüm, 131
M-protein / M-protein, 131
Myeloma / Miyelom, 89, 181, 182, 352
Infection / Enfeksiyon, 181
Atlas / Atlas, 181
Fracture / Kırık, 181
Acquired hemophilia / Edinsel hemofili, 184
Factor VIII / Faktör VIII, 184
Autoantibody / Otoantikor, 184
Coagulation disorder / Koagülasyon bozukluğu, 184
CD56 / CD56, 226
CD117 / CD117, 226
Flow cytometry / Akım sitometri, 226
Relapse refractory / Relaps refrakter, 233
Bendamustine / Bendamustin, 233
Distal arteriovenous fistula / Distal arteriyovenöz fistül, 268
Multislice computer tomography / Çok kesitli bilgisayarlı tomografi, 268
Hemodialysis / Hemodiyaliz, 268
Plasmacytoma / Plazmasitom, 352
Intracranial / İntrakraniyal, 352
Monoclonal gammopathy of renal significance / Renal öneme
sahip monoklonal gammopati, 282
Plasma cell disorders / Plazma hücre hastalıkları, 282
Renal involvement / Böbrek tutulumu, 282
Kidney / Böbrek, 282
Cast nephropathy / Kast nefropati, 282
Myelodysplastic Syndromes
Refractory anemia with ring sideroblasts / Halka sideroblastlı refrakter
anemi, 100
RARS with thrombocytosis / Trombositoz ile birlikte RARS, 100
Myelodysplastic syndrome/myeloproliferative neoplasm with ring
sideroblasts and thrombocytosis / Halka sideroblast ve trombositoz ile
birlikte miyelodisplastik sendrom/miyeloproliferatif neoplazi, 100
Myelodysplastic syndromes / Miyelodisplastik sendromlar, 200
Telomere-binding proteins / Telomer-bağlayıcı proteinler, 200
Reverse transcription-polymerase chain reaction / Ters
transkripsiyon-polimeraz zincir reaksiyonu, 200
International Prognostic Scoring System /
Uluslararası Prognoz Skorlama Sistemi, 200
World Health Organization Prognostic Scoring System /
Dünya Sağlık Örgütü Prognoz Skorlama
Sistemi, 200
Myeloproliferative Disorders
Chronic myeloproliferative neoplasms / Kronik
miyeloproliferatif neoplaziler, 27
Treatment / Tedavi, 27
Survival / Sağkalım, 27
JAK2 mutation / JAK2 mutasyonu, 27
Primary myelofibrosis / Primer miyelofibroz, 124, 360
Internuclear bridging / Nükleuslar arası köprüleşme, 124
Erythrocytes / Eritrositler, 124